- Phosphoinositide 3-kinase inhibition enables retinoic acid-induced neurogenesis in monolayer culture of embryonic stem cells2012 | Lékařská fakulta v Plzni
- Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry2018 | 2. lékařská fakulta
- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | 2. lékařská fakulta, 1. lékařská fakulta
- Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)2023 | Publikace bez příslušnosti k fakultě
- Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: A large patient cohort study2017 | 2. lékařská fakulta
- Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome2014 | 2. lékařská fakulta
- Interleukin-22 promotes the proliferation and migration of hepatocellular carcinoma cells via the phosphoinositide 3-kinase (PI3K/AKT) signaling pathway2023 | Lékařská fakulta v Plzni
- Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity2023 | 2. lékařská fakulta
- Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib2017 | 2. lékařská fakulta
- The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation2003 | Ústřední knihovna
- Novel caffeine derivatives with antiproliferative activity2016 | Lékařská fakulta v Hradci Králové
- Onemocnění gastrointestinálního traktu u nemocných s primárními imunodeficity2017 | Lékařská fakulta v Hradci Králové
- The interaction of p130Cas with PKN3 promotes malignant growth2019 | Přírodovědecká fakulta
- A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development2023 | Přírodovědecká fakulta
- Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)2022 | Publikace bez příslušnosti k fakultě
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové, Ústřední knihovna
- Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU70262012 | Lékařská fakulta v Hradci Králové
- Molecular and Cellular Mechanisms Associated with Effects of Molecular Hydrogen in Cardiovascular and Central Nervous Systems2020 | 1. lékařská fakulta
- Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C32019 | Farmaceutická fakulta v Hradci Králové
- mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma2023 | 1. lékařská fakulta, 3. lékařská fakulta
- Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment2022 | 1. lékařská fakulta
- Randomized, Placebo-Controlled, Phase 3 Trial of PI3Kδ Inhibitor Leniolisib for Activated PI3Kδ Syndrome2023 | 2. lékařská fakulta
- Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS2024 | 2. lékařská fakulta